IBD

Biologics Gastroenterology IBD PBS Pharmaceuticals

IBD patients caught in Australia’s medicines access gap

Biologics Gastroenterology IBD Research

Biologic dose escalation in IBD improves outcomes, reduces healthcare utilisation

Gastroenterology IBD

Call for shift from treating disease to redesigning care

IBD Obesity Research

IBD more prevalent in obese populations

IBD MBS pathology

Half a win: calprotectin MBS listing

Clinical Diet Gastro Guidelines IBD Nutrition

New IBD guideline settles the diet debate